Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for HyponatremiaRobert W. Schrier, Cesare Orlandi|New England Journal of Medicine|2006Cited by 1.2k
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B. Chapman, David C. Wheeler, Dwight Odland et al.|Kidney International|2015Cited by 602
Hypertonicity-induced Aquaporin-1 (AQP1) Expression Is Mediated by the Activation of MAPK Pathways and Hypertonicity-responsive Element in the AQP1 GeneFuminori Umenishi, Robert W. Schrier|Journal of Biological Chemistry|2003Cited by 163